Cancer drug and uses
AssigneeHealth Clinics Limited
InventorsRobin M. Bannister, John Brew, Gregory A. Stoloff
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.
Claims21
A pharmaceutical kit comprising an anti-diabetic drug, a statin, and a glycolysis inhibitor.
The pharmaceutical kit comprising a biguanide, a statin, a benzimidazole, and a cytotoxic antibiotic.
The pharmaceutical kit comprising a metformin, an atorvastatin, a mebendazole, and a doxycycline.
Dependencies are inferred from the claim text.